Olink proteomics profiling reveals metabolism-related protein biomarkers in diabetic retinopathy
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Qiu-Yang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jia…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Biomarkers, Proteomics, Aqueous Humor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic retinopathy (DR) represents a microvascular complication of diabetes mellitus that is associated with metabolic dysregulation. This study employed Olink proteomics profiling to identify novel biomarkers and elucidate the potential mechanism of DR. A total of 44 patients with DR and 44 individuals with cataracts serving as controls were enrolled in the study. Aqueous humor samples from all participants were analyzed for 92 metabolism-related proteins using the Olink® Metabolism Panel. Differential expression analysis identified 78 proteins with altered expression between the two groups. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differentially expressed proteins revealed that the enriched pathways were primarily associated with blood vessel development, cellular signaling, and protein degradation. Notably, TFF2 exhibited exceptional diagnostic potential for DR with an area under the curve (AUC) of 0.9974 in receiver operating characteristic (ROC) analysis. Elevated TFF2 levels were further validated in both DR patients and a streptozotocin (STZ)-induced diabetic murine model. Functional experiments revealed that TFF2 contributed to endothelial angiogenic effects in vitro and retinal vascular dysfunction in vivo. These findings underscore the potential of TFF2 as a diagnostic biomarker for DR and offer new insights into the metabolic pathways driving DR pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
- The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China.
- The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, 210000, China. Electronic address: jinyao1972@126.com.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. Electronic address: yanbiao@sjtu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Q. Y., Zhang, H. Y., Liu, Q., Wang, F. S., Zhu, Y., Feng, S. G., Yao, J., & Yan, B. (2025). Olink proteomics profiling reveals metabolism-related protein biomarkers in diabetic retinopathy. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110495
Vancouver
Zhang QY, Zhang HY, Liu Q, Wang FS, Zhu Y, Feng SG, et al. Olink proteomics profiling reveals metabolism-related protein biomarkers in diabetic retinopathy. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110495
BibTeX
@article{Zhang2025,
author = {Zhang, Qiu-Yang and Zhang, Hui-Ying and Liu, Qing and Wang, Feng-Sheng and Zhu, Yue and Feng, Si-Guo and Yao, Jin and Yan, Biao},
title = {Olink proteomics profiling reveals metabolism-related protein biomarkers in diabetic retinopathy},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110495}
}
EUVIMED